我要投票 上海医药在化学药物行业中的票数:58
· 外 推 电 报 ·
2025-01-19 16:55:23 星期日

【上海医药是哪个国家的品牌?】

上海医药是什么牌子?「上海医药」是 上海医药集团股份有限公司 旗下著名品牌。该品牌发源于上海市,由创始人周军在1994-01-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

上海医药集团股份有限公司是中国唯一一家在医药产品和分销市场方面均居领先地位的医药上市公司,公司研发以创新为长期坚持的方向,致力于为重大疾病和慢性病提供安全有效的治疗药物,2012年研发投入占公司制药业务销售收入4.72%。公司建立了以中央研究院为技术核心的集团总院分院研发体系,拥有1个国家级企业技术中心以及10个省市级企业技术中心,入选十余项“重大新药创制”国家科技重大专项。公司采用开放式研究模式,与中国科学院上海药物所建立了创新药物研发战略联盟,与中国药科大学、沈阳药科大学等建立联合实验室,与日本三菱田边制药株式会社、上海复旦张江生物医药等合作开展创新药物研发;同时,还通过项目引进、合作开发等方法开始进入治疗性抗体领域。

上海医药制造覆盖化学和生物药品、现代中药和保健品、医疗器械等领域,产品聚焦心脑血管类、全身性抗感染类、消化系统和免疫代谢类、神经精神类、抗肿瘤类五大治疗领域,生产片剂、胶囊、粉针(含冻干)、小容量注射液、滴眼剂、气雾剂、凝胶剂等20种以上剂型,过亿产品20个。公司旗下的信谊、雷氏、龙虎、青春宝、胡庆余堂、苍松、国风、神象等多个品牌为中国驰名商标。公司药品生产严格执行中国新版GMP要求,有多个原料药或制剂通过了WHO、FDA、欧盟以及其他发达国家的质量认证。

上海医药的分销网络以中国经济最发达的华东、华北、华南三大重点区域为中心辐射全国各地,业务规模排名全国第二。公司分销业务以医院纯销为主,并与全球40多家跨国药企开展合作。公司的疫苗、高端耗材、DTP(高值药品直送)及SPD(医药物流管理技术)等新业务发展在国内处于领先地位。公司分销服务正逐步走向以供应链延伸服务和临床支持服务为核心的医院现代服务解决方案,为医院客户提供终端解决方案、专项物流和信息化服务。

上海医药零售拥有华氏、雷允上、余天成、人寿天、雷蒙、科园信海大药房等诸多知名品牌,覆盖全国12个省、直辖市及自治区,门店总数1792家。2012年公司药品零售销售规模居全国药品零售行业前五位,上海华氏大药房为华东地区拥有药房最多的企业。上海医药的零售业务包括连锁药店、合办药房、DTP药房等多种业态,并积极发展电子商务实现网上销售。

上海医药倡导“创新、诚信、合作、包容、责任”的企业核心价值观,致力于持之以恒,提升民众的健康生活品质,努力打造受人尊敬、拥有行业美誉度的领先品牌药制造商和健康领域服务商。



英文翻译:Shanghai Pharmaceutical Group Co., Ltd. is the only pharmaceutical listed company in China that has a leading position in both pharmaceutical products and distribution market. The company's R & D takes innovation as the long-term direction and is committed to providing safe and effective treatment drugs for major diseases and chronic diseases. In 2012, the R & D investment accounted for 4.72% of the company's pharmaceutical business sales revenue. The company has established a R & D system with the Central Research Institute as the technical core of the group's General Institute and branch, with 1 national enterprise technology center and 10 provincial and municipal enterprise technology centers, and has been selected into more than 10 national science and technology major projects of "major new drug creation". The company adopts an open research mode, establishes a strategic alliance for innovative drug research and development with Shanghai Institute of pharmaceutical science, Chinese Academy of Sciences, a joint laboratory with China Pharmaceutical University, Shenyang Pharmaceutical University, etc., and carries out innovative drug research and development in cooperation with Japan Mitsubishi taganabe Pharmaceutical Co., Ltd., Shanghai Fudan Zhangjiang biomedical Co., Ltd.; at the same time, it also starts through project introduction, cooperative development and other methods Enter the field of therapeutic antibody. Shanghai pharmaceutical manufacturing covers chemical and biological medicine, modern Chinese medicine and health products, medical devices and other fields, products focus on cardiovascular, systemic anti infection, digestive system and immune metabolism, neuropsychiatric, anti-tumor five treatment areas, producing tablets, gels, powder injection (including freeze-dried), small volume injection, eye drops, aerosol, gel and so on 20 kinds. More than 20 over 100 million products. Xinyi, Leishi, Longhu, qingqingyutang, Cangsong, Guofeng, Shenxiang and other brands under the company are well-known trademarks in China. The company strictly implements the new GMP requirements in China, and several APIs or preparations have passed the quality certification of who, FDA, EU and other developed countries. Shanghai Pharmaceutical's distribution network centers on the three key regions of East China, North China and South China, which are the most developed regions in China. Its business scale ranks the second in China. The company's distribution business is mainly hospital pure sales, and cooperates with more than 40 multinational pharmaceutical companies around the world. The company's vaccine, high-end consumables, DTP (direct delivery of high-value drugs) and SPD (pharmaceutical logistics management technology) and other new business development are in a leading position in China. The company's distribution service is gradually moving towards a modern hospital service solution with the core of supply chain extension service and clinical support service, providing terminal solutions, special logistics and information services for hospital customers. Shanghai Pharmaceutical retail has many famous brands such as Huashi pharmacy, leiyunshang pharmacy, yutiancheng pharmacy, lifetian pharmacy, Leimeng pharmacy, Keyuan Xinhai pharmacy, covering 12 provinces, municipalities and autonomous regions, with a total number of 1792 stores. In 2012, the company's drug retail sales scale ranked the top five in the national drug retail industry, and Shanghai Huashi pharmacy is the enterprise with the largest number of pharmacies in East China. Shanghai Pharmaceutical's retail business includes chain drugstores, joint drugstores, DTP drugstores and other formats, and actively develops e-commerce to achieve online sales. Shanghai Pharmaceutical advocates the core values of "innovation, integrity, cooperation, inclusiveness and responsibility". It is committed to persevere, improve people's healthy life quality, and strive to build a respected leading brand drug manufacturer and health service provider with industry reputation.

本文链接: https://www.waitui.com/brand/9b09c6ba1.html 联系电话:02163730908

千城特选小程序码

7×24h 快讯

TikTok向用户推送关停通知

36氪获悉,TikTok向用户推送了关停通知:我们很遗憾,一项封禁TikTok的美国法律将于1月19日生效,并迫使我们暂时停止提供服务。我们正尽快努力在美国恢复我们的服务,我们感谢各位的支持。请保持关注。

56分钟前

2025年春节档刷新中国影史预售票房破千万最快纪录

1月19日,据灯塔专业版,2025年春节档1月19日开启预售,仅用时40分钟,档期预售总票房突破1000万,刷新中国影史预售最快破千万纪录,影片《射雕英雄传:侠之大者》领跑。

56分钟前

2024年全球显示器出货量1.27亿台 同比上涨1.5%

1月19日,根据洛图科技最新发布的《全球显示器市场品牌整机出货月度追踪》报告数据显示,2024年全年,全球显示器市场品牌整机的出货量为1.27亿台,与2023年相比上涨1.5%。戴尔在2024年的全球出货量为23.7百万台,位居当年出货量第一,同比微幅上涨0.2%。预测2025年全球显示器出货量仍然保持稳定的增长态势,达到1.29亿台,涨幅约为2%。

56分钟前

不止TikTok 字节旗下海外应用或将同步停服

1月19日,美东时间周六晚上9点左右,字节跳动旗下TikTok开始向美国用户发送关停通知。另据记者了解, 字节跳动旗下剪映海外版CapCut同步发布了停服信息。另一款海外产品Lemon8也有可能停服,目前官方暂未对该消息进行确认。Lemon8形式类似TikTok短视频与Instagram及Pinterest的结合,也像另一种形式的小红书海外版。2023年,Lemon8在美国市场上线。近一个月,Lemon8已在苹果应用商店排行榜连续排名靠前。据接近TikTok方面人士表示,根据美国“不卖就禁”法律,字节跳动旗下所有应用都将面临与TikTok相似的遭遇。 (第一财经)

56分钟前

TikTok在美国停止服务

TikTok向美国用户推送信息称,“很抱歉,TikTok 目前无法使用。美国已经颁布了一项禁止 TikTok 的法律。很遗憾,这意味着你暂时无法使用 TikTok。幸运的是,特朗普总统(即将上任)表示,他上任后将与我们共同努力寻找解决方案,以恢复 TikTok 的使用。请持续关注!”(界面新闻)

56分钟前

本页详细列出关于易乎生物的品牌信息,含品牌所属公司介绍,易乎生物所处行业的品牌地位及优势。
咨询